Capital International LTD Allakos Inc. Transaction History

Capital International LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$109.73 - $153.66 $175,677 - $246,009	-1,601 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$79.58 - $152.45 $127,407 - $244,072	1,601 New	1,601 $224,000
Q2 2020 Aug 14, 2020	SELL	$44.04 - $80.69 $145,155 - $265,954	-3,296 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$44.49 - $93.39 $146,639 - $307,813	3,296 New	3,296 $147,000

104

70.7M

43.8K

1.4K

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $55.1M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

Get notified when there are updates to the investment portfolio of Capital International LTD , based on Form 13F filings with the SEC.

Stay updated on Capital International LTD with notifications on news.